Jasper Therapeutics, Inc., (JSPR): Price and Financial Metrics
JSPR Price/Volume Stats
Current price | $4.93 | 52-week high | $26.83 |
Prev. close | $4.87 | 52-week low | $3.13 |
Day low | $4.86 | Volume | 215,300 |
Day high | $5.09 | Avg. volume | 417,624 |
50-day MA | $4.70 | Dividend yield | N/A |
200-day MA | $13.58 | Market Cap | 74.06M |
JSPR Stock Price Chart Interactive Chart >
Jasper Therapeutics, Inc., (JSPR) Company Bio
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company develops JSP191, a humanized monoclonal antibody for clearing hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It also develops Jasper eHSC Platform to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.
JSPR Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | -76.17% |
1-year | -78.58% |
3-year | -84.35% |
5-year | N/A |
YTD | -76.94% |
2024 | 170.98% |
2023 | 63.39% |
2022 | -93.85% |
2021 | -21.58% |
2020 | N/A |
Loading social stream, please wait...